tiprankstipranks
Advertisement
Advertisement

LQDA Stock Latest News

Constructive Buy Thesis on Liquidia Driven by Pulmonary Hypertension Opportunity and Upcoming Value Catalysts
RatingsConstructive Buy Thesis on Liquidia Driven by Pulmonary Hypertension Opportunity and Upcoming Value Catalysts
16d ago
LQDA
Insmed price target lowered to $175 from $208 at Wells Fargo
PremiumThe Fly
Insmed price target lowered to $175 from $208 at Wells Fargo
1M ago
INSM
LQDA
Liquidia price target raised to $51 from $44 at Wells Fargo
PremiumThe Fly
Liquidia price target raised to $51 from $44 at Wells Fargo
1M ago
INSM
LQDA
United Therapeutics price target raised to $486 from $466 at Wells Fargo
PremiumThe Fly
United Therapeutics price target raised to $486 from $466 at Wells Fargo
1M ago
INSM
LQDA
Liquidia Technologies put volume heavy and directionally bearish
PremiumThe Fly
Liquidia Technologies put volume heavy and directionally bearish
2M ago
LQDA
Liquidia price target raised to $19 from $16 at Oppenheimer
PremiumThe FlyLiquidia price target raised to $19 from $16 at Oppenheimer
2M ago
LQDA
Liquidia rises 7.7%
Premium
The Fly
Liquidia rises 7.7%
2M ago
LQDA
Liquidia price target raised to $55 from $50 at H.C. Wainwright
Premium
The Fly
Liquidia price target raised to $55 from $50 at H.C. Wainwright
2M ago
LQDA
Liquidia: Exceptional Yutrepia Launch, Advancing PH Pipeline, and Strengthening Financial Profile Support Buy Rating
PremiumRatings
Liquidia: Exceptional Yutrepia Launch, Advancing PH Pipeline, and Strengthening Financial Profile Support Buy Rating
2M ago
LQDA
Liquidia: Strong Yutrepia Uptake and Sustained Profitability Support Buy Rating
PremiumRatings
Liquidia: Strong Yutrepia Uptake and Sustained Profitability Support Buy Rating
2M ago
LQDA
Liquidia files automatic mixed securities shelf
PremiumThe Fly
Liquidia files automatic mixed securities shelf
2M ago
LQDA
Liquidia reports Q4 EPS 15c, consensus 33c
PremiumThe Fly
Liquidia reports Q4 EPS 15c, consensus 33c
2M ago
LQDA
LQDA Earnings this Week: How Will it Perform?
PremiumPre-EarningsLQDA Earnings this Week: How Will it Perform?
2M ago
LQDA
Liquidia (LQDA): Durable Competitive Edge and Sustainable Market Share Despite TreSMI Launch Supports Buy Rating
Premium
Ratings
Liquidia (LQDA): Durable Competitive Edge and Sustainable Market Share Despite TreSMI Launch Supports Buy Rating
2M ago
LQDA
Liquidia reaction on United Therapeutics’ TreSMI reveal ‘overdone,’ says Needham
Premium
The Fly
Liquidia reaction on United Therapeutics’ TreSMI reveal ‘overdone,’ says Needham
2M ago
LQDA
UTHR
Maintaining Buy on Liquidia: Overreaction to TreSMI News and Attractive Risk-Reward Ahead of ’327 Patent Ruling
PremiumRatings
Maintaining Buy on Liquidia: Overreaction to TreSMI News and Attractive Risk-Reward Ahead of ’327 Patent Ruling
2M ago
LQDA
Liquidia Technologies call volume above normal and directionally bullish
PremiumThe Fly
Liquidia Technologies call volume above normal and directionally bullish
4M ago
LQDA
Liquidia price target raised to $55 from $45 at Jefferies
PremiumThe Fly
Liquidia price target raised to $55 from $45 at Jefferies
4M ago
LQDA
Liquidia: Robust Yutrepia Launch Trajectory and Market Leadership Prospects Justify Buy Rating Despite Patent Overhang
PremiumRatings
Liquidia: Robust Yutrepia Launch Trajectory and Market Leadership Prospects Justify Buy Rating Despite Patent Overhang
4M ago
LQDA
Liquidia rises 18.2%
PremiumThe FlyLiquidia rises 18.2%
4M ago
LQDA
Liquidia falls -6.5%
Premium
The Fly
Liquidia falls -6.5%
4M ago
LQDA
Liquidia highlights strong YUTREPIA launch and growth plans
Premium
Company Announcements
Liquidia highlights strong YUTREPIA launch and growth plans
4M ago
8K
LQDA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >